Continue
By using our website you accept our cookies policy.Find out more

New strategic partnership program to further develop Fujifilm's capabilities in bioprocessing

Posted on 06/02/2019

Fujifilm has announced the inception of the FDB Centre of Excellence in Bioprocessing 2.0 in partnership with leading UK academic institutions.

FUJIFILM Diosynth Biotechnologies (Fujifilm), a leading Contract Development and Manufacturing Organisation (CDMO) with experience in the development and manufacture of recombinant biopharmaceuticals and gene therapies, has announced the inception of the “FDB Centre of Excellence in Bioprocessing 2.0” (CEB) in the United Kingdom. This initiative is an extension of Fujifilm’s global innovation initiatives.

The Centre of Excellence will be led and funded by Fujifilm Diosynth Biotechnologies, in partnership with leading academic institutions – University of Edinburgh; and University of Manchester, and University of York. This initiative was jointly defined by Fujifilm and CEB Partners to address challenges and opportunities in bioprocessing.

Andy Topping, chief scientific officer at Fujifilm, said:

“Fujifilm has historically supported a significant number of innovation projects globally. The FDB Centre of Excellence in Bioprocessing 2.0 builds on Fujifilm’s historical support of research here in the United Kingdom and allows us to develop long term partnerships with these world class universities to support the growth of our business.”

Formal announcement of the establishment of the CEB took place at the Industrial Biotechnology Innovation Centre (IBioIC) Annual Conference 2019, ‘Industrial Biotechnology for a Sustainable Future’, held on 30th-31st January 2019 at the Technology Innovation Centre, Glasgow. The IBioIC’s Annual Conference is the leading general industrial biotechnology conference in the UK. The conference celebrates the success of the biotechnology industry in the United Kingdom and provides delegates with networking opportunities needed to drive new collaborations.  Fujifilm is a core member of the IBioIC, which provides access to funding, events and access to other companies within its network.

Jen Vanderhoven, Vice President of global business change, said:

“Our aim is to link fundamental research and world class expertise to the business needs of Fujifilm,” said . “We are creating an innovation engine that drives new processes, efficiencies, products and services.”

CEB related activities will commence in 2019.

Related Content

Biophysical techniques for studying components of biological membranes
The Biochemical Society is running a training workshop on membrane proteins on 3-5 April in Leeds.
UK highlighted as a synthetic biology hotspot
A SynBioBeta article has highlighted the UK's world-leading synthetic biology research and companies.
Industrial biotechnology funding round-up
Find out about the latest funding calls of relevance to industrial biotechnology. Updated 18th April.